文献速递甲状腺疾病

调查左甲状腺素的使用及其与甲状腺健康的关系:一项社区药房研究

Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study.
PubMed 文献 · Thyroid · 2023-05-15

在比利时社区药房开展横断面观察研究,纳入856例使用左甲状腺素(LT4)≥2年的甲减成人。约四分之一TSH超出范围,28%依从性差,仅39%在餐前≥30分钟服药;LT4使用方式与TSH或健康相关生活质量无显著相关。

要点

  • 约四分之一参与者(138/563)TSH水平超出范围。
  • 仅39%(329/836)遵循LT4在餐前≥30分钟服用的建议。
  • LT4使用(依从性、服药时间、与结合药物相互作用)与TSH或HR-QoL无显著相关。

核心结论

  • 许多甲减患者未尽可能有效地使用LT4,尤其在给药时间方面。
  • 参与者的健康相关生活质量似乎基本满意,正确使用LT4与甲状腺健康之间无显著相关。

研究设计与样本

  • 在比利时社区药房样本中开展的横断面观察研究,纳入使用LT4治疗甲减≥2年的成人。
  • 共纳入856名参与者(平均年龄61.4±14.3岁,86%[740/856]为女性)。
  • 参与者完成自填问卷(患者特征、自报依从性、服药时间、合并用药)和甲状腺特异性患者报告结局(ThyPRO-39)问卷,并使用药房配药数据计算药物持有率(MPR)。

主要发现

  • 约四分之一参与者(138/563)TSH水平超出范围。
  • ThyPRO-39评分总体处于范围较低部分(提示较好HR-QoL),其中「情绪易感性」和「疲倦」量表评分最差。
  • 约28%(178/632)参与者被归类为不依从(MPR<80%),相当于每年至少累计73天未服用LT4。
  • 25%(212/854)参与者自报不依从,其中非故意不依从(遗忘)报告最多(21.9%,187/854)。
  • 仅39%(329/836)参与者遵循LT4在餐前≥30分钟服用的建议;7%(58/856)参与者同时使用与LT4结合的分子而未采用推荐给药间隔。

关键数值与推荐

  • 不依从定义为MPR<80%,对应每年至少累计73天未服用LT4。
  • 推荐LT4在餐前≥30分钟服用。
  • 使用与LT4结合的分子时应采用推荐给药间隔。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: To gain maximum therapeutic effect while minimizing side effects, it is imperative for patients with hypothyroidism to use their levothyroxine (LT4) correctly, such as adhering to the prescribed regimen. Little is currently known about how patients actually use LT4 in real life. We investigated the use of LT4, as well as the thyroid health (thyrotropin [TSH] and health-related quality of life [HR-QoL]), and evaluated if proper LT4 use is associated with better thyroid health. Methods: A cross-sectional observational study was conducted in a Belgian community sample of adults using LT4 for hypothyroidism since ≥2 years. Participants completed a self-administered questionnaire on patient characteristics, self-reported adherence to LT4, timing of intake, and co-medication. They also completed the thyroid-specific patient-reported outcome (ThyPRO-39) questionnaire, measuring the HR-QoL. Pharmacy dispensing data were used to calculate the medication possession ratio (MPR). Results: We included 856 participants (mean age 61.4 ± 14.3 years, 86% [740/856] females). Approximately one in four participants (138/563) had out-of-range TSH levels. Generally, ThyPRO-39 scores were in the lower part of the range (indicating better HR-QoL), with the scales "emotional susceptibility" and "tiredness" showing the worst scores. Approximately 28% (178/632) of the participants were classified as non-adherent (MPR <80%), corresponding to at least 73 cumulative days per year without LT4 intake. Twenty-five percent (212/854) of participants self-reported non-adherence, with unintentional non-adherence (forgetfulness) most frequently reported (21.9%, 187/854). Only 39% (329/836) of participants complied with the recommendation of ingesting LT4 ≥ 30 minutes before eating. Additionally, 7% (58/856) of participants concurrently used molecules that bind to LT4, without applying the recommended dosing interval. There was no significant correlation between LT4 usage (adherence, timing of intake, and interaction with complex forming drugs) and TSH or HR-QoL. Conclusions: We found that many participants with hypothyroidism did not use their LT4 as effectively as possible, particularly with respect to timing of administration. However, the participants' HR-QoL seemed largely satisfactory, and there was no significant correlation between correctly using LT4 and thyroid health.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Mehuys E, Lapauw B, T'Sjoen G, et al. Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study. Thyroid. 2023. PMID: 37184683. doi:10.1089/thy.2023.0066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。